273 related articles for article (PubMed ID: 19096009)
1. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation.
Sampath D; Calin GA; Puduvalli VK; Gopisetty G; Taccioli C; Liu CG; Ewald B; Liu C; Keating MJ; Plunkett W
Blood; 2009 Apr; 113(16):3744-53. PubMed ID: 19096009
[TBL] [Abstract][Full Text] [Related]
2. Forodesine has high antitumor activity in chronic lymphocytic leukemia and activates p53-independent mitochondrial apoptosis by induction of p73 and BIM.
Alonso R; López-Guerra M; Upshaw R; Bantia S; Smal C; Bontemps F; Manz C; Mehrling T; Villamor N; Campo E; Montserrat E; Colomer D
Blood; 2009 Aug; 114(8):1563-75. PubMed ID: 19541822
[TBL] [Abstract][Full Text] [Related]
3. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
[TBL] [Abstract][Full Text] [Related]
4. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2.
Taebunpakul P; Sayan BS; Flinterman M; Klanrit P; Gäken J; Odell EW; Melino G; Tavassoli M
Apoptosis; 2012 Aug; 17(8):762-76. PubMed ID: 22484480
[TBL] [Abstract][Full Text] [Related]
5. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
Ray RM; Bhattacharya S; Johnson LR
Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-protein ligase Itch regulates p73 stability.
Rossi M; De Laurenzi V; Munarriz E; Green DR; Liu YC; Vousden KH; Cesareni G; Melino G
EMBO J; 2005 Feb; 24(4):836-48. PubMed ID: 15678106
[TBL] [Abstract][Full Text] [Related]
7. p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia.
Rivetti di Val Cervo P; Tucci P; Majid A; Lena AM; Agostini M; Bernardini S; Candi E; Cohen G; Nicotera P; Dyer MJ; Melino G
Blood; 2009 Jun; 113(25):6498-9; author reply 6499-500. PubMed ID: 19541840
[No Abstract] [Full Text] [Related]
8. MDM2 promotes the proteasomal degradation of p73 through the interaction with Itch in HeLa cells.
Kubo N; Okoshi R; Nakashima K; Shimozato O; Nakagawara A; Ozaki T
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):405-11. PubMed ID: 21093410
[TBL] [Abstract][Full Text] [Related]
9. The BH3-only protein Puma plays an essential role in p53-mediated apoptosis of chronic lymphocytic leukemia cells.
Zhu HJ; Liu L; Fan L; Zhang LN; Fang C; Zou ZJ; Li JY; Xu W
Leuk Lymphoma; 2013 Dec; 54(12):2712-9. PubMed ID: 23517560
[TBL] [Abstract][Full Text] [Related]
10. The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.
Jung YS; Qian Y; Chen X
J Biol Chem; 2011 Oct; 286(41):35388-35395. PubMed ID: 21852228
[TBL] [Abstract][Full Text] [Related]
11. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73.
Levy D; Adamovich Y; Reuven N; Shaul Y
Cell Death Differ; 2007 Apr; 14(4):743-51. PubMed ID: 17110958
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptotic genes by a p73-phosphatase and tensin homolog (p73-PTEN) protein complex in response to genotoxic stress.
Lehman JA; Waning DL; Batuello CN; Cipriano R; Kadakia MP; Mayo LD
J Biol Chem; 2011 Oct; 286(42):36631-40. PubMed ID: 21873427
[TBL] [Abstract][Full Text] [Related]
13. Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73.
Kawahara M; Hori T; Chonabayashi K; Oka T; Sudol M; Uchiyama T
Blood; 2008 Nov; 112(9):3856-66. PubMed ID: 18565851
[TBL] [Abstract][Full Text] [Related]
14. CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.
Dicker F; Kater AP; Prada CE; Fukuda T; Castro JE; Sun G; Wang JY; Kipps TJ
Blood; 2006 Nov; 108(10):3450-7. PubMed ID: 16741250
[TBL] [Abstract][Full Text] [Related]
15. A regulatory circuit controlling Itch-mediated p73 degradation by Runx.
Levy D; Reuven N; Shaul Y
J Biol Chem; 2008 Oct; 283(41):27462-27468. PubMed ID: 18701449
[TBL] [Abstract][Full Text] [Related]
16. miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Zenz T; Mohr J; Eldering E; Kater AP; Bühler A; Kienle D; Winkler D; Dürig J; van Oers MH; Mertens D; Döhner H; Stilgenbauer S
Blood; 2009 Apr; 113(16):3801-8. PubMed ID: 18941118
[TBL] [Abstract][Full Text] [Related]
17. P73 status in B-cell chronic lymphocytic leukaemia.
Leupin N; Lüthi A; Novak U; Grob TJ; Hügli B; Graber H; Fey MF; Tobler A
Leuk Lymphoma; 2004 Jun; 45(6):1205-7. PubMed ID: 15360002
[TBL] [Abstract][Full Text] [Related]
18. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
19. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.
Wu H; Zeinab RA; Flores ER; Leng RP
Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467
[TBL] [Abstract][Full Text] [Related]
20. E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry.
Alla V; Kowtharapu BS; Engelmann D; Emmrich S; Schmitz U; Steder M; Pützer BM
Cell Cycle; 2012 Aug; 11(16):3067-78. PubMed ID: 22871739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
